Zambia, Zimbabwe address TB/HIV co-infection

The Center for Global Health Policy's "Science Speaks" blog outlines efforts to fight TB/HIV co-infection in Zambia and Zimbabwe. In Zambia, a partnership among the Centre for Infectious Disease Research in Zambia with funding from PEPFAR and Zambia's Ministry of Health began a pilot program in several prisons to identify and treat prisoners infected with TB or HIV, the blog notes, writing, "A prison service medical directorate has been established and the government is opening more open air prisons to ensure infection control." The blog writes that in Zimbabwe, "[t]o respond to the need to scale up [antiretroviral treatment (ART)] access for TB patients, the country is piloting a one-stop shop for co-infected patients where antiretroviral treatment and TB treatment are provided by the same nurse in the same day" (Lubinski, 4/16).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

 

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New two-dose HIV vaccine strategy shows promise for stronger immune response